The cancer treatment technology developer's series C was led by Philips Health Technology Ventures and backed by Debiopharm and Cerner.
US-based, oncology-focused health technology developer Carevive Systems has completed an $18m series C round led by Philips Health Technology Ventures, an investment vehicle for medical device and electronics group Philips.
The round included pharmaceutical company Debiopharm’s Innovation Fund, health IT equipment producer Cerner, Qure Ventures, HLM Venture Partners, LRVHealth, OurCrowd’s digital health fund and Carevive founder Madelyn Trupkin Herzfeld.
Carevive has created technology that helps physicians remotely monitor the condition of cancer patients and manage their treatment. It secured…
